Stock analysts at StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX - Get Free Report) in a research report issued on Wednesday. The firm set a "hold" rating on the software maker's stock.
Separately, Stephens lifted their price objective on shares of Veradigm from $7.00 to $13.00 and gave the stock an "equal weight" rating in a research report on Friday, January 31st.
Read Our Latest Report on Veradigm
Veradigm Stock Up 3.5 %
Shares of MDRX stock traded up $0.15 during trading hours on Wednesday, hitting $4.40. 3,698 shares of the company were exchanged, compared to its average volume of 466,039. The business has a 50 day moving average of $5.30 and a two-hundred day moving average of $8.19. Veradigm has a 52 week low of $4.00 and a 52 week high of $11.80.
Veradigm Company Profile
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
